Interventional Oncology

What do we treat?

Interventional oncology stands at the forefront of modern cancer care, nestled within the realm of Interventional Radiology (IR). This specialized field focuses on diagnosing and treating cancer and its related challenges through precise, minimally invasive procedures guided by imaging technologies. Utilizing X-ray, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), interventional oncologists navigate miniature instruments—such as biopsy needles, ablation electrodes, and intravascular catheters—to deliver targeted therapies for solid tumors, also known as neoplasms. These interventions can effectively target tumors in various organs, including the liver, kidneys, lungs, and bones.

Big Hope in a Small Package

• Among the groundbreaking advancements in interventional oncology lies a technique known as radioembolization. At Clemenceau Medical Center, Dr. Kabalane Yammine has pioneered this approach, performing the first three cases in Lebanon.

• Radioembolization, an outpatient procedure, delivers radiation directly to the tumor site. Using a catheter, interventional radiologists introduce millions of microspheres—tiny particles emitting radiation—into the blood vessels supplying the tumor(s). These microspheres become lodged, obstructing the tumor(s) blood supply and eradicating malignant cells that may be unreachable through other means.

Why Choose Radioembolization for Primary and Metastatic Liver Tumors??

• Radioembolization presents a compelling option for patients with inoperable primary and metastatic liver tumors. Furthermore, it can complement other treatment modalities such as chemotherapy and serve as a preparatory step before radiofrequency ablation, surgery, or transplantation.

• This localized approach addresses common challenges associated with traditional cancer treatments by precisely targeting radiation to the affected areas. Healthy liver tissue remains largely unscathed, minimizing side effects such as fatigue, nausea, or vomiting.

• Radioembolization offers renewed optimism and extended survival rates for individuals grappling with primary and metastatic liver cancer. Moreover, it significantly improves the quality of life by reducing therapy-related discomfort, hastening recovery, and mitigating adverse effects.